Ara-C treatment caused a decrease in microglia, NG2+ progenitors, oligodendrocytes, astrocytes and T cells in the spinal cord of SOD1^G93A mice. by Jean-Nicolas Audet (326107)

Constitutive KIT activation in cells with gain-of function KIT mutations causes increased ROS levels and decreased DJ-1. by Do-Kyun Kim (2176492)

SDG decreases iron-induced inflammatory cytokine gene expression in H9c2 cells. by Stephanie Puukila (568109)

SDG decreases iron-induced caspase 3/7 activity in H9c2 cells. by Stephanie Puukila (568109)

S1 Data - by Alexander Hu (14755811)

Subjects:

Time-resolved EELS spectra, as a function of decreasing water vapor pressure. by Cathal Cassidy (1758703)

<i>Ang1</i>-KO mice develop more severe colitis compared to WT mice. by Alexander Hu (14755811)

Subjects:

<i>Ang1</i>-deficient mice are associated with alterations in the gut microbiome. by Alexander Hu (14755811)

Subjects:

Experimental protocol. by Alexander Hu (14755811)

Subjects:

<i>Ang1</i>-deficient mice develop significantly fewer tumors compared to WT mice following AOM-DSS. by Alexander Hu (14755811)

Subjects:

Differential <i>Ang1</i> and <i>Ang4</i> mRNA expression following AOM-DSS exposure. by Alexander Hu (14755811)

Subjects:

Downregulation of G9a induces autophagy and decreases tumorigenicity in neuroblastoma cells. by Xiao-Xue Ke (626989)

The effect of STOX1A on cell proliferation in the neuroblastoma cell-line SH-SY5Y. by Daan van Abel (214754)

“…(C) Overexpression and knockdown of STOX1A was determined with quantitative RT-PCR showing a mean 21 fold (mean ΔΔCt 4.4) increase in mRNA expression for STOX1A in stably transfected SH-SH5Y cells compared to the controls (Left bar) and a mean 71 fold (mean ΔΔCt 6.15) decreased mRNA expression for STOX1A siRNA transfected SH-SY5Y cells compared to the scrambled controls (right bar). …”

Schematic illustration of the possible steps of ‘stalk mechanism’ of the electrofusion of two ‘single GUVs’. by Md. Tariqul Islam Bhuiyan (18794375)

The SW480 cells were treated with the S100A1 (blue, Lanes 2, 3 and 4). by Md. Imran Khan (4853302)

Values for the calculation of the time-dependent drug concentrations in the system based on observed data found and derived from a variety of sources. by J. Roadnight Sheehan (20141887)

THS exposure in conjunction with antioxidant treatment for 2.5 and 5 months alleviates metabolic syndrome in a dose-dependent manner. by Neema Adhami (516427)

“…<p><b>(A)</b> THS-exposed mice treated with antioxidants for 5 months have reduced visceral fat accumulation compared to THS exposed mice. …”

The CaM-binding mutation in PC1 decreases macroscopic current through PC1/PC2 channels. by Nicholas Doerr (2446855)

Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis by Laura V. Minard (349145)

“…The overall proportion of NSSPP beneficiaries dispensed a statin increased approximately 4-fold during the study period. …”

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)